Rethinking Thin-Layer Chromatography for Screening Technetium-99m Radiolabeled Polymer Nanoparticles.


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 26 06 2024
revised: 12 08 2024
accepted: 21 08 2024
pmc-release: 30 08 2025
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 19 9 2024
Statut: epublish

Résumé

Thin-layer chromatography (TLC) is commonly employed to screen technetium-99m labeled polymer nanoparticle batches for unreduced pertechnetate and radio-colloidal impurities. Although this method is widely accepted, our findings applying radiolabeled PLGA/PLA-PEG nanoparticles underscore its lack of transferability between different settings and its limitations as a standalone quality control tool. While TLC profiles may appear similar for purified and radiocolloid containing nanoparticle formulations, their in vivo behavior can vary significantly, as demonstrated by discrepancies between TLC results and single-photon emission computed tomography (SPECT) and biodistribution data. This highlights the urgent need for a case-by-case evaluation of TLC methods for each specific nanoparticle type. Our study revealed that polymeric nanoparticles cannot be considered analytically uniform entities in the context of TLC analysis, emphasizing the complex interplay between nanoparticle composition, radiolabeling conditions, and subsequent biological behavior.

Identifiants

pubmed: 39296255
doi: 10.1021/acsptsci.4c00383
pmc: PMC11406700
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2604-2611

Informations de copyright

© 2024 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Auteurs

Kathrin Schorr (K)

Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Bavaria 93053, Germany.

Xinyu Chen (X)

Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Bavaria 86156, Germany.

Takanori Sasaki (T)

Department of Nuclear Medicine and Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Bavaria 97080, Germany.
Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-0082, Japan.

Anahi Paula Arias-Loza (AP)

Department of Nuclear Medicine and Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Bavaria 97080, Germany.

Johannes Lang (J)

Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Bavaria 93053, Germany.

Takahiro Higuchi (T)

Department of Nuclear Medicine and Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Bavaria 97080, Germany.
Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-0082, Japan.

Achim Goepferich (A)

Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Bavaria 93053, Germany.

Classifications MeSH